Dr. Danielle Demontigny Avila, MD

Dr. Avila practices at University of Arizona in Tucson, Arizona.

Dr. Avila's NPI, 1154715365, was assigned on March 25, 2015. Dr. Avila holds Montana license MED-RES-LIC-42281.

Dr. Avila's primary practice is University of Arizona, at 1501 N Campbell Ave, Tucson, AZ 85724 in Pima County. The practice phone is (520) 626-2761.

Dr. Avila's primary practice is University of Arizona in Tucson, Arizona. Dr. Avila is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Avila to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Avila practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Avila's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Avila is licensed in Montana.

CMS data shows 162 Medicare services from Dr. Avila across 6 procedure codes in 2024, for 98 Medicare patients. Medicare paid $15,581 for them.

CMS counts 98 Medicare patients who saw Dr. Avila in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Avila's median patient age at 62, with 35% women.

In 2024, Dr. Avila wrote 498 Medicare Part D claims for 59 patients. 38% of them were for generic drugs. CMS names the drug for 346 of them, across 10 drugs with 11 or more claims each, at $955,175 in total drug cost. In 2023, CMS named 247 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Avila for performance year 2024, reported through an alternative payment model (APM). Dr. Avila accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Avila from 2 drug and device companies from 2021 to 2025. Education make up the largest share, 85% of the total. Insmed, Inc. paid the most, $117.